Skip to main content
All lobbying filings

DANA-FARBER CANCER INSTITUTE

Lobbying for DANA-FARBER CANCER INSTITUTE

 Filing 1st Quarter - Report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Expenses
$50,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Massachusetts

Official filing document

 Government bodies contacted 4
  • Food & Drug Administration (FDA)
  • HOUSE OF REPRESENTATIVES
  • President of the U.S.
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 3
  • HR 1509
    Accelerating Kids’ Access to Care Act of 2025
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
  • HR 1300
    PSA Screening for HIM Act
 Lobbying activity 5
Budget/Appropriations

Funding related to biomedical and cancer research and innovation at the NIH and NCI, funding for Childhood Cancer research, funding for ARPA-H in the Labor, Health and Human Services, Education bill; funding for cancer prevention and smoking cessation programs at the CDC.

Health Issues

Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.

Medicare/Medicaid

Issues related to health care access and reimbursement through the Medicare and Medicaid programs including site neutrality and prior authorization policies in the Medicare and Medicare Advantage program

Medical/Disease Research/Clinical Labs

Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including 1509/ S 752 the Accelerating Kids Access to Care Act and HR 1262 the Give Kids a Chance Act

Tobacco

Support for FDA's role to vigorously enforce the Family Smoking Prevention and Tobacco Control Act including the regulation of flavors, menthol and small cigars. Support for continued funding for the CDCs Office on Smoking and Health.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem